Surmodics Inc Sustainability Reports
The company provides surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300H76KXCAAGUS878
FIGI: BBG001SBL623
6 reports from 2010 to 2024